PLUS THERAPEUTICS INC (PSTV:NASDAQ)
$5.4 0.6 (12.5%)
Analysed PLUS THERAPEUTICS INC (PSTV:NASDAQ) News Sources
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
09-04-2026
yahoo.com
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
08-04-2026
yahoo.com
D. Boral Capital Downgrades Plus Therapeutics (PSTV) to Hold
07-04-2026
yahoo.com
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
07-04-2026
yahoo.com
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
02-04-2026
yahoo.com
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
31-03-2026
yahoo.com
Plus Therapeutics Announces Reverse Stock Split
31-03-2026
yahoo.com
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
26-03-2026
yahoo.com
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
19-03-2026
yahoo.com
Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4
12-03-2026
yahoo.com
What is the current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The current price of PLUS THERAPEUTICS INC (PSTV:NASDAQ) is $5.4.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) absolute price change since previous trading day?
The absolute price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is $0.6.
PLUS THERAPEUTICS INC (PSTV:NASDAQ) percentage price change since previous trading day?
The percentage price change of PLUS THERAPEUTICS INC (PSTV:NASDAQ) since the previous trading day is 12.5%.
What is the most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent average sentiment score for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ)?
The most recent sentiment for PLUS THERAPEUTICS INC (PSTV:NASDAQ) is .
SEC-8K** Filing Available For PLUS THERAPEUTICS INC (PSTV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.